Executive function and dopamine response in Parkinson's disease freezing of gait

Parkinsonism Relat Disord. 2021 Nov:92:46-50. doi: 10.1016/j.parkreldis.2021.10.015. Epub 2021 Oct 18.

Abstract

Background: This investigation examined whether aspects of attention and executive functioning differed between Parkinson's Disease (PD) patients with freezing of gait (FOG) based on responsiveness to dopamine. We also explored association of cognition with FOG severity and gait metrics.

Methods: Fifty-four individuals with PD completed the study protocol: 17 without freezing (PDC), 23 with dopa-responsive FOG (RFOG), and 14 with dopa-unresponsive (URFOG). Standardized neuropsychological tests assessed attention (focused and sustained), psychomotor speed, and set-switching (time and errors). FOG severity was measured using the new FOG Questionnaire (nFOG-Q). Metrics from timed up and go (TUG) tasks were obtained while "on" and "off" dopamine, with and without dual cognitive tasks.

Results: After controlling for clinical and demographic factors, analysis of covariance revealed a significant between-group difference for set-switching errors; planned contrasts revealed increased set-switching errors in URFOG relative to RFOG and PD control groups. Groups were not different in other cognitive domains. FOG severity was modestly associated with set-switching errors in RFOG but not URFOG. TUG performances while "on" were associated with set-switching errors in PD controls, and with focused attention in RFOG.

Conclusion: PD patients with dopa-unresponsive FOG are more prone to set-switching errors than those who respond to treatment. Furthermore, executive function appears relevant to FOG severity only in patients who show dopamine response. Together, these findings suggest disruption of a common dopamine-mediated pathway for FOG and ability to monitor rules while alternating cognitive processes. Consideration of dopa-response could be useful in characterizing cohorts and treating FOG in PD.

Keywords: Cognition; Dopa-response; Executive function; Freezing of gait; Parkinson.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antiparkinson Agents / therapeutic use*
  • Attention / drug effects
  • Dopamine / therapeutic use*
  • Executive Function / drug effects*
  • Female
  • Gait Disorders, Neurologic / etiology
  • Gait Disorders, Neurologic / psychology*
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / psychology
  • Severity of Illness Index
  • Task Performance and Analysis
  • Time and Motion Studies
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Dopamine